Latest Posts
About This Stock
More About This Stock
Read
Trump, Biogen And Amgen Hammer Healthcare ETFs
Article By:
Sweta Killa
Monday, March 20, 2017 2:05 PM EDT
The initial sell-off came after Trump’s budget blueprint, which signaled higher regulatory costs for the sector and a cut in federal funding for medical research.